![Image](https://i0.wp.com/euis.eu/wp-content/uploads/2019/11/21_11_19_small.jpg?w=150&ssl=1)
An innovative Swedish SME will soon launch a life-saving test for one of the most lethal and hard-to-detect forms of cancer. Clinically validated in an EU-funded project, the test could revolutionise the diagnosis of pancreatic cancer, providing early detection with unprecedented accuracy, boosting patient survival rates and enabling widespread screening of high-risk groups.
Powered by WPeMatico
Related
Comments
comments